- Home
- TCBX vs CCCC Comparison
TCBX vs CCCC Comparison
Compare TCBX & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBX
- CCCC
- Stock Information
- Founded
- TCBX 2008
- CCCC 2015
- Country
- TCBX United States
- CCCC United States
- Employees
- TCBX N/A
- CCCC N/A
- Industry
- TCBX Banks
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- TCBX Finance
- CCCC Health Care
- Exchange
- TCBX Nasdaq
- CCCC Nasdaq
- Market Cap
- TCBX 473.0M
- CCCC 396.0M
- IPO Year
- TCBX 2021
- CCCC 2020
- Fundamental
- Price
- TCBX $34.25
- CCCC $3.95
- Analyst Decision
- TCBX Buy
- CCCC Buy
- Analyst Count
- TCBX 4
- CCCC 6
- Target Price
- TCBX $25.50
- CCCC $10.67
- AVG Volume (30 Days)
- TCBX 85.4K
- CCCC 1.9M
- Earning Date
- TCBX 01-23-2025
- CCCC 10-31-2024
- Dividend Yield
- TCBX N/A
- CCCC N/A
- EPS Growth
- TCBX 38.69
- CCCC N/A
- EPS
- TCBX 2.56
- CCCC N/A
- Revenue
- TCBX $158,911,000.00
- CCCC $33,668,000.00
- Revenue This Year
- TCBX N/A
- CCCC $75.79
- Revenue Next Year
- TCBX $8.54
- CCCC N/A
- P/E Ratio
- TCBX $13.35
- CCCC N/A
- Revenue Growth
- TCBX 17.73
- CCCC 65.45
- 52 Week Low
- TCBX $18.00
- CCCC $3.61
- 52 Week High
- TCBX $37.65
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- TCBX 46.12
- CCCC 41.77
- Support Level
- TCBX $36.07
- CCCC $3.61
- Resistance Level
- TCBX $37.37
- CCCC $4.06
- Average True Range (ATR)
- TCBX 1.36
- CCCC 0.44
- MACD
- TCBX -0.43
- CCCC 0.01
- Stochastic Oscillator
- TCBX 26.41
- CCCC 22.82
About TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company has one segment, community banking, it generates most of its revenue from interest on loans, customer service, and loan fees.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.